Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis

Table 3

Relationship of clinical characteristics of ovarian cancer patients and signature in TCGA cohort.

Characteristics	High-risk ()	Low-risk ()	value
Age			0.528
Mean (years)
Stage			0.033
I	4	11
II	9	16
III	202	208
IV	48	30
NA	3	1
Grade			0.123
G1	5	1
G2	40	27
G3	214	232
G4	0	1
NA	7	5
Residual tumor size			<0.001
No macroscopic	36	70
1-10 mm	134	100
11-20 mm	20	14
>20 mm	55	45
NA	21	37
Lymphatic invasion			0.067
Yes	75	57
No	31	47
NA	160	163
Venous invasion			0.003
Yes	52	34
No	22	45
NA	192	187
KPS			0.058
40	0	2
60	7	8
80	13	27
100	2	5
NA	244	224
Therapy outcome			0.006
Complete remission/response	133	165
Partial remission/response	40	20
Progressive disease	24	12
Sable disease	14	16
NA	55	53
Neoplasm cancer status			0.002
With tumor	184	150
Tumor free	50	85
NA	32	31
New neoplasm event type			0.081
Locoregional disease	5	1
Metastatic	1	0
Progression of disease	12	15
Recurrence	143	121
NA	105	129